NuSkin Enterprises, Inc. logo

NuSkin Enterprises, Inc. (NUS)

Common Stock · Currency in USD · XNYS

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

Company Info

SIC5122
Composite FIGIBBG000HG21Y3
CIK0001021561
IPONov 22, 1996
Sectorwholesale-drugs, proprietaries & druggists' sundries

Highlights

Market Cap$356.62M
EPS$1.40
P/E Ratio5.22
Revenue$1.50B
Gross Profit$1.03B
Net Income$68.32M
Employees8,600
WSO48,126,825
Phone801-345-1000

Related Tickers

Analysis

Share Price Chart

Performance Chart

The chart shows the growth of an initial investment of $10,000 in NuSkin Enterprises, Inc., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.

Returns By Period

NuSkin Enterprises, Inc. (NUS) has returned -23.21% so far this year and 18.94% over the past 12 months. Looking at the last ten years, NUS has achieved an annualized return of -15.24%, underperforming the Benchmark (SPY), which averaged 12.23% per year.

NUS

1M-1.07%
6M-34.83%
YTD-23.21%
1Y18.94%
5Y-32.23%
10Y-15.24%

Benchmark (SPY)

1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%

Monthly Returns

The table below presents the monthly returns of NuSkin Enterprises, Inc. (NUS) with color gradation from worst to best to easily spot seasonal factors.

JanFebMarAprMayJunJulAugSepOctNovDec
20269.95%-20.00%-11.76%1.93%
2025-5.76%21.85%-8.68%-12.69%37.64%-5.33%4.49%45.23%3.04%-11.04%-7.91%-2.83%
2024-4.08%-33.16%10.02%-14.41%13.33%-22.27%5.55%-20.62%-16.53%-16.24%15.87%-3.64%
20231.44%-6.89%-1.31%-15.81%-0.45%-11.32%-18.99%-12.14%-9.57%-9.85%14.44%
2022-4.82%-3.82%3.75%-11.61%9.35%-7.85%-0.21%-5.45%-18.13%13.46%7.42%1.39%
20215.85%-12.33%2.38%-0.55%13.40%-5.94%-5.61%-5.65%-20.62%-1.57%9.26%13.71%
2020-20.69%-24.99%-11.50%39.10%29.41%2.93%17.07%5.07%6.17%-2.06%3.02%5.57%
20198.33%-8.59%-20.41%6.05%-23.17%5.75%-20.01%1.60%5.40%4.75%-14.76%7.17%
20184.19%-2.36%4.11%-2.73%15.44%-5.01%-6.60%9.51%3.18%-15.24%-6.52%-8.13%
20178.02%-5.28%11.48%-1.25%-1.53%14.46%0.57%-4.46%0.70%3.38%5.84%0.74%
20167.29%-3.14%17.44%15.36%8.33%10.87%-4.71%-15.36%-8.75%

Performance Indicators

The charts below present risk-adjusted performance metrics for NuSkin Enterprises, Inc. (NUS) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.

Sharpe ratio

-2.00-1.000.001.002.003.00NUS: 0.33SPY: 0.92

Sortino ratio

-6.00-4.00-2.000.002.004.00NUS: 0.49SPY: 1.40

Omega ratio

0.501.001.502.00NUS: 1.07SPY: 1.22

Calmar ratio

0.002.004.006.00NUS: 0.07SPY: 1.20

Martin ratio

0.001.003.00NUS: 0.06SPY: 0.42

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.

The chart below shows the rolling Sharpe ratio of NUS compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Volatility Chart

The current NuSkin Enterprises, Inc. volatility is 1.21%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.

Income Statement

The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.

202520242023202220212020201920182017201620152014201320122011
Liabilities And Equity (USD)1.41B1.47B1.81B1.82B1.91B1.96B1.77B1.69B1.59B1.47B1.51B1.61B1.82B1.15B990.96M
Equity Attributable To Parent (USD)805.24M651.46M821.97M897.30M912.77M894.27M875.29M781.87M704.60M664.07M825.62M942.44M858.62M590.61M574.24M
Equity Attributable To Noncontrolling Interest (USD)---------------
Equity (USD)805.24M651.46M821.97M897.30M912.77M894.27M875.29M781.87M704.60M664.07M825.62M942.44M858.62M590.61M574.24M
Other Non-current Liabilities (USD)----------18.73M876.00K3.98M48.21M39.00M
Long-term Debt (USD)----------253.90M252.79M181.68M193.98M136.55M
Noncurrent Liabilities (USD)336.34M520.85M655.62M564.43M464.01M519.95M536.96M472.92M437.91M410.96M272.63M253.67M185.65M242.19M175.55M
Other Current Liabilities (USD)212.47M232.95M241.03M267.63M426.06M411.41M287.17M323.88M358.86M332.34M378.77M383.62M694.11M272.22M208.99M
Wages (USD)25.08M28.77M44.34M37.65M53.64M65.27M30.61M68.16M38.17M25.41M-----
Accounts Payable (USD)26.18M34.88M43.51M53.96M49.99M66.17M38.98M47.62M50.34M41.26M28.83M34.71M82.68M47.88M32.18M
Current Liabilities (USD)263.73M296.61M328.87M359.24M529.69M542.86M356.76M439.66M447.37M399.01M407.60M418.33M776.79M320.10M241.17M
Liabilities (USD)600.07M817.46M984.50M923.67M993.71M1.06B893.72M912.58M885.28M809.98M680.22M672.00M962.44M562.30M416.72M
Other Non-current Assets (USD)437.83M476.44M566.32M549.60M502.87M496.17M494.92M340.69M279.85M251.42M277.91M239.92M223.52M231.20M228.03M
Intangible Assets (USD)42.61M74.28M105.31M66.70M76.99M89.53M80.32M89.99M67.65M63.55M67.01M75.06M83.17M92.52M83.33M
Fixed Assets (USD)377.17M379.60M432.97M444.81M453.67M468.18M453.60M464.54M464.59M444.73M454.54M464.78M396.04M229.79M149.51M
Noncurrent Assets (USD)857.62M930.32M1.10B1.06B1.03B1.05B1.03B895.21M812.08M759.71M799.45M779.77M702.73M553.50M460.87M
Other Current Assets (USD)369.06M348.36M421.89M413.69M473.02M588.83M464.28M503.42M524.34M464.40M441.14M496.18M778.67M463.53M417.98M
Inventory (USD)178.64M190.24M279.98M346.18M399.93M314.37M275.89M295.82M253.45M249.94M265.26M338.49M339.67M135.87M112.11M
Current Assets (USD)547.70M538.60M701.87M759.87M872.95M903.20M740.17M799.24M777.79M714.34M706.39M834.67M1.12B599.40M530.09M
Assets (USD)1.41B1.47B1.81B1.82B1.91B1.96B1.77B1.69B1.59B1.47B1.51B1.61B1.82B1.15B990.96M

News and Insights

Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%

The global derma roller market is expected to grow from $303.14 million in 2023 to $668.17 million by 2033, driven by increasing demand for non-invasive cosmetic procedures and growing interest in skincare products.

GlobeNewswire Inc. faviconGlobeNewswire Inc.Spherical Insights & Consulting
Why Nu Skin Enterprises Stock Flopped on Friday

Nu Skin Enterprises (NUS) shares fell over 3% after the company reported a 12% year-over-year decline in Q2 revenue and a steep drop in non-GAAP net income, despite beating analyst estimates. The company provided guidance for Q3 and full-year 2024, but the earnings forecast fell short of expectations.

The Motley Fool faviconThe Motley FoolEric Volkman
Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates

Nu Skin (NUS) delivered earnings and revenue surprises of 80% and 3.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research faviconZacks Investment ResearchZacks Equity Research
Nu Skin (NUS) Q1 Earnings Coming Up: Factors to Consider

Nu Skin's (NUS) first-quarter 2024 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations are a concern.

Zacks Investment Research faviconZacks Investment ResearchZacks Equity Research